France· FR:62102962
STAMARIL, poudre et solvant pour suspension injectable en seringue préremplie. Vaccin de la fièvre jaune (Vivant)
A medicinal product containing virus de la fièvre jaune, souche 17d-204 (vivant, atténué), registered in France by SANOFI WINTHROP INDUSTRIE.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- VIRUS DE LA FIÈVRE JAUNE, SOUCHE 17D-204 (VIVANT, ATTÉNUÉ)
- Manufacturer
- SANOFI WINTHROP INDUSTRIE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip1334009369933101 flacon(s) en verre de 1 dose(s) - 1 seringue(s) préremplie(s) en verre de 0,5 ml avec deux aiguille(s) séparées
- cip13340093699348810 flacon(s) en verre de 1 dose(s) - 10 seringue(s) préremplie(s) en verre de 0,5 ml avec deux aiguille(s) séparées
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Virus de la fièvre jaune, souche 17d-204 (vivant, atténué) in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSTAMARILSanofi Pasteur, Lyon
- NetherlandsStamaril, poeder en oplosmiddel voor suspensie voor injectie in een voorgevulde spuitMedcor Pharmaceuticals B.V.
- United KingdomArilvax vaccine powder and solvent for suspension for injection 0.5ml vialsNovartis Vaccines and Diagnostics Ltd
- United StatesYF-VAXSanofi Vaccines US Inc.
- GermanyStamarilSanofi Winthrop Industrie
- IrelandSTAMARIL, powder and solvent for suspension for injection in pre-filled syringe. Yellow fever vaccine (Live)Sanofi Winthrop Industrie
- IcelandStamarilSanofi Winthrop Industrie
- SwitzerlandStamaril, poudre et solvant pour suspension injectableSanofi-Aventis (Suisse) SA
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Stamaril
- Belgium · Stamaril
- Bulgaria · Стамарил
- Cyprus · Stamaril
- Czechia · Stamaril
- Germany · Stamaril
- Denmark · Stamaril
- Estonia · Stamaril
- Spain · Stamaril
- Finland · Stamaril
- United Kingdom (Northern Ireland) · Stamaril
- Hungary · Stamaril
- Ireland · Stamaril
- Iceland · Stamaril
- Italy · Stamaril
- Lithuania · Stamaril
- Luxembourg · Stamaril
- Latvia · Stamaril
- Malta · Stamaril
- Netherlands · Stamaril
- Norway · Stamaril
- Poland · Stamaril
- Portugal · Stamaril
- Romania · Stamaril
- Sweden · Stamaril
- Slovakia · Stamaril
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1933534d-0291-4131-a593-2e920214d339 GET /v1/drugs/1933534d-0291-4131-a593-2e920214d339?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62102962",
"date_amm": "1986-01-27",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "VIRUS DE LA FIÈVRE JAUNE, SOUCHE 17D-204 (VIVANT, ATTÉNUÉ)",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour suspension injectable",
"voies_administration": "intramusculaire;sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about virus de la fièvre jaune, souche 17d-204 (vivant, atténué).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.